Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy

OBJECTIVES: To investigate if inflammation detected by MRI or ultrasound at rheumatoid arthritis (RA) onset is predictive of erosive progression or poor response to methotrexate monotherapy, and to investigate if subclinical inflammation in remission is predictive of future treatment escalation or e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundin, Ulf, Sundlisater, Nina Paulshus, Aga, Anna-Birgitte, Sexton, Joseph, Nordberg, Lena Bugge, Hammer, Hilde Berner, van der Heijde, Desirée, Kvien, Tore K, Haavardsholm, Espen A, Lillegraven, Siri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871342/
https://www.ncbi.nlm.nih.gov/pubmed/33547228
http://dx.doi.org/10.1136/rmdopen-2020-001525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871342/
https://www.ncbi.nlm.nih.gov/pubmed/33547228
http://dx.doi.org/10.1136/rmdopen-2020-001525

Ejemplares similares